Shypd.aiThe largest open index of AI toolsMOLCURE Inc. accelerates drug discovery through an AI-driven molecular design platform. It combines proprietary large language models, physics-based simulations, and in-house biolab data to discover effective biotherapeutics.
Trending
About
MOLCURE Inc. is an AI company dedicated to accelerating drug discovery by integrating machine learning, biotechnology, and robotics. Their core technology is an evolving AI platform featuring specialized algorithms for biological data and a rapid in-house learning loop. Key strengths include a proprietary Antibody Large Language Model (LLM) built from scratch, a database with over 1 billion proprietary datapoints, and an in-house wet lab for directed evolution experiments and next-generation sequencing. MOLCURE offers various collaboration models, including end-to-end support for AI-driven molecular design, AI-powered de novo discovery of novel molecules, and AI-driven lead optimization for existing candidate molecules. They also provide consulting services to leverage AI technologies in drug discovery processes.
Capabilities
Pricing & Plans
Custom
Not publicly disclosed. Check molcure.com for current pricing.
FAQs
Trending
